PASIFOLATE EXATECAN
UNII 9NL385N34R

Substance Identification & Data

This profile provides standardized clinical and technical data for Pasifolate Exatecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9NL385N34R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2622895-25-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9NL385N34R

CAS Registry Number

2622895-25-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PASIFOLATE EXATECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C187021

National Cancer Institute reference terminology for clinical and research data.

USAN ID

KL-57

Identifier assigned by the United States Adopted Names Council.

Substance Type

polymer

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pasifolate Exatecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PASIFOLATE EXATECAN

Common Names & Synonyms

ELU 001 [WHO-DD]

PASIFOLATE EXATECAN [USAN]

Systematic Nomenclature

SILSESQUIOXANES, 3-(CYCLOPENTADIEN-1-YL)PROPYL 3-HYDROXYPROPYL 3-MERCAPTOPROPYL, ETHERS WITH POLYETHYLENE GLYCOL MONO-ME ETHER, POLYMERS WITH SILICIC ACID (H4SIO4) TETRA-ME ESTER, REACTION PRODUCTS WITH N2-(4-(((2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-N-(2-(2-(2-(2-AZIDOETHOXY)ETHOXY)ETHOXY)ETHYL)-L-GLUTAMINE, N-(30-AZIDO-1-OXO-4,7,10,13,16,19,22,25,28-NONAOXATRIACONT-1-YL)-L-VALYL-N-(4-((((((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)CARBONYL)OXY)METHYL)PHENYL)-L-LYSINAMIDE, N-(19-(11,12-DIDEHYDRODIBENZ(B,F)AZOCIN-5(6H)-YL)-15,19-DIOXO-3,6,9,12-TETRAOXA-16-AZANONADEC-1-YL)-2,5-DIHYDRO-2,5-DIOXO-1H-PYRROLE-1-PROPANAMIDE AND 2-(5-(1-(6-((2-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)ETHYL)AMINO)-6-OXOHEXYL)-1,3-DIHYDRO-3,3-DIMETHYL-2H-INDOL-2-YLIDENE)-1,3-PENTADIEN-1-YL)-1,3,3-TRIMETHYL-3H-INDOLIUM CHLORIDE (1:1)

SYS